Wells Fargo & Company MN raised its position in shares of Amedisys Inc (NASDAQ:AMED) by 29.7% in the third quarter, according to its most recent filing with the SEC. The firm owned 1,484,041 shares of the health services provider’s stock after purchasing an additional 339,825 shares during the quarter. Wells Fargo & Company MN owned approximately 4.38% of Amedisys worth $83,048,000 at the end of the most recent quarter.

A number of other large investors have also recently added to or reduced their stakes in the business. Vanguard Group Inc. grew its position in shares of Amedisys by 0.7% during the 2nd quarter. Vanguard Group Inc. now owns 2,386,046 shares of the health services provider’s stock worth $149,867,000 after buying an additional 16,368 shares during the period. American Century Companies Inc. grew its position in shares of Amedisys by 41.4% during the 3rd quarter. American Century Companies Inc. now owns 1,671,680 shares of the health services provider’s stock worth $93,547,000 after buying an additional 489,220 shares during the period. Dimensional Fund Advisors LP grew its position in shares of Amedisys by 0.7% during the 2nd quarter. Dimensional Fund Advisors LP now owns 1,124,943 shares of the health services provider’s stock worth $70,658,000 after buying an additional 7,963 shares during the period. Bank of New York Mellon Corp grew its position in shares of Amedisys by 10.8% during the 3rd quarter. Bank of New York Mellon Corp now owns 846,575 shares of the health services provider’s stock worth $47,375,000 after buying an additional 82,247 shares during the period. Finally, Northern Trust Corp grew its position in shares of Amedisys by 2.8% during the 2nd quarter. Northern Trust Corp now owns 804,167 shares of the health services provider’s stock worth $50,510,000 after buying an additional 21,581 shares during the period. 94.32% of the stock is owned by institutional investors and hedge funds.

Amedisys Inc (NASDAQ:AMED) opened at $52.65 on Wednesday. The company has a debt-to-equity ratio of 0.16, a quick ratio of 1.33 and a current ratio of 1.33. Amedisys Inc has a 52 week low of $38.00 and a 52 week high of $65.91. The firm has a market capitalization of $1,790.00, a price-to-earnings ratio of 25.30, a price-to-earnings-growth ratio of 1.28 and a beta of 0.70.

Amedisys (NASDAQ:AMED) last issued its quarterly earnings data on Tuesday, November 7th. The health services provider reported $0.56 earnings per share for the quarter, beating the consensus estimate of $0.54 by $0.02. Amedisys had a return on equity of 14.68% and a net margin of 2.88%. The business had revenue of $380.20 million for the quarter, compared to analysts’ expectations of $384.59 million. During the same period last year, the business earned $0.36 EPS. The business’s revenue was up 5.1% on a year-over-year basis. equities research analysts anticipate that Amedisys Inc will post 2.23 earnings per share for the current year.

Several analysts recently issued reports on AMED shares. BidaskClub raised shares of Amedisys from a “sell” rating to a “hold” rating in a research report on Friday, August 11th. Bank of America started coverage on shares of Amedisys in a research report on Monday, August 21st. They issued a “neutral” rating and a $55.00 price target for the company. Oppenheimer reissued a “buy” rating and issued a $60.00 price target on shares of Amedisys in a research report on Friday, September 15th. Robert W. Baird reissued a “hold” rating and issued a $50.00 price target on shares of Amedisys in a research report on Wednesday, October 4th. Finally, SunTrust Banks reissued a “buy” rating and issued a $60.00 price target on shares of Amedisys in a research report on Monday, October 9th. Six investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and an average target price of $61.00.

ILLEGAL ACTIVITY NOTICE: “Amedisys Inc (AMED) Holdings Increased by Wells Fargo & Company MN” was published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this story on another domain, it was copied illegally and republished in violation of United States & international trademark & copyright legislation. The legal version of this story can be accessed at https://www.thecerbatgem.com/2017/12/06/amedisys-inc-amed-holdings-increased-by-wells-fargo-company-mn.html.

About Amedisys

Amedisys, Inc is a healthcare services company. The Company’s segments are Home Health, Hospice, Personal Care and Other. The Company is a provider of home health, hospice and personal care services. As of December 31, 2016, the Company owned and operated 327 Medicare-certified home healthcare centers, 79 Medicare-certified hospice care centers and 14 personal-care care centers in 34 states within the United States and the District of Columbia.

Want to see what other hedge funds are holding AMED? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amedisys Inc (NASDAQ:AMED).

Institutional Ownership by Quarter for Amedisys (NASDAQ:AMED)

Receive News & Stock Ratings for Amedisys Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amedisys Inc and related stocks with our FREE daily email newsletter.